Navigation Links
Adheron Therapeutics Names New Senior Leadership
Date:9/11/2013

SAN FRANCISCO, Sept. 11, 2013 /PRNewswire/ -- Adheron Therapeutics, a biotechnology company that is focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases, has announced the appointments of Robert Baltera as executive chairman of the board and Hari Kumar as chief executive officer, effective immediately.

Baltera and Kumar served most recently as senior officers of Amira Pharmaceuticals, which was acquired by Bristol Myers Squibb for $325M upfront and $150M in milestones. At Adheron Therapeutics - previously known as Synovex Corporation – Baltera and Kumar's focus will be developing the company's novel Cadherin-11 technology for various therapeutic indications.

"I am very excited about my new role at Adheron Therapeutics. I am deeply impressed by the innovative technology that we are developing and I look forward to advancing it to the next level," said Kumar.

The company's therapeutic program is based on pioneering work completed in the laboratory of Michael Brenner, MD, at Brigham and Women's Hospital and Harvard Medical School. Prof. Brenner discovered that the protein Cadherin-11 (Cad-11) acts as an "adhesive" between cells, and that changes in Cad-11 interactions can induce cells to produce proteins that influence the cellular environment positively or adversely. Further research by Dr. Brenner confirmed that Cad-11 acts as a key mediator of joint destruction in rheumatoid arthritis, and is also an important contributor to pulmonary and skin fibrosis pathology. 

Baltera added: "Cadherin-11 is a very promising technology, which I am confident will be applied in various areas of high unmet medical need. I am pleased to lead Adheron and I am confident we will see exciting results."

Based on Dr. Brenner's research, Adheron Therapeutics has developed an
'/>"/>

SOURCE Adheron Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Case Report Suggests Microbiome Therapeutics NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
2. Echo Therapeutics Sends Response to Shareholder Letter
3. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
4. Orexigen Therapeutics Prepares for the Light Study Interim Analysis Based on Direction from Data Monitoring Committee
5. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
6. AML Therapeutics Market in the 6MM Worth $430.7m in 2017 Says a New Research Report Available at ReportsnReports.com
7. Global Lung Cancer Therapeutics Market 2013 Report Featuring Leading Players Such As AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline, Hoffmann-La Roche, Novartis And Others
8. Oncology Therapeutics Market in India to 2018 Report
9. PTC Therapeutics Announces Achievement Of Major Milestone In SMA Collaboration
10. NuMe Health Becomes MicroBiome Therapeutics And Recruits New CEO
11. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Nashville Fertility Center announced that ... for the American Society for Reproductive Medicine (ASRM), a ... in reproductive medicine. In his new role as ... executive board and will have a voice in furthering ... actively supported ASRM since 1984 when he joined while ...
(Date:12/24/2014)... BEIJING , Dec. 23, 2014 ... or the "Company"), a leading fully integrated plasma-based ... today announced that its majority-owned subsidiary, Shandong Taibang ... Practices ("GMP") certification from the China Food and ... factor production facility. As previously disclosed in the ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The ... global leader of technical training across the life sciences ... Data Management (SCDM) to provide the organization's members ... programs —providing access to the more than 350 sessions ... members with 10% off when registering for a ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... , CAMBRIDGE, Mass. , April 28 ... Research Awards Program.  Given annually, the awards will fund ... of diseases and other important human traits. To inaugurate ... interpretation services to three winning research groups, each of ...
... ... browsers enable researchers to quickly and effectively use these invaluable resources. , ... Seattle, WA (PRWEB) April 26, 2010 -- OpenHelix ... on the Overview of Genome Browsers. , , , Ensembl is a genome browser ...
... , LELYSTAD and ,S-HERTOGENBOSCH, The Netherlands ... based biotechnology firm focusing on,protein mimicking technology for the generation of ... therapeutic vaccine,portfolio with Immunovo BV of ,s-Hertogenbosch. Under the terms of ... a,minority interest in Immunovo. , ...
Cached Biology Technology:Knome Announces KnomeDISCOVERY Research Awards Program 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 3Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 2Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 3
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "iPhone 5S Fingerprint Sensor ... report to their offering. ... acquisition of AuthenTec in July 2012, Apple introduced ... It is currently the only device of Apple ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics ... pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred ... has served as a meeting place for peoples from ... the ongoing mixing of peoples with African, European, and ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... EUGENE, Ore.(Aug. 20, 2007)Nitric acid is a notoriously strong and ... our atmosphere. However, a team of researchers have found that ... top of a water surface. The discovery of the ... the surface of water requires us to re-evaluate how we ...
... of G&D, Drs. Maria Divina Deato and Robert Tjian ... alternative transcriptional core promoter complex directs cell-type specific differentiation ... of transcriptional control of terminal cell differentiation, and will ... date at www.genesdev.org . For nearly 30 ...
... after prior full-dose conventional radiation therapy respond to Boron ... a Phase I/II study at the Helsinki University Hospital, ... Heikki Joensuu, University of Helsinki, considers the results ... field for BNCT, since thus far BNCT has been ...
Cached Biology News:University of Oregon researcher finds that on water's surface, nitric acid is not so tough 2A new radiation therapy treatment developed for head and neck cancer patients 2
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
Acetylcholinesterase from human and monkey....
Excellent safety and durability., Remote control can be easily operated in your hand., Constant voltage control with 2 sets of terminals., Precise and durable circuit design. ...
... systems. , Integrated Instrument Control , ... EZChrom Elite can be configured with a ... provides a completely integrated system to control instrument's operation, collect andstore ... ...
Biology Products: